Pharma and Healthcare Insights & Analytics
PHARMA
| Business Description | Products/Services | ||
|---|---|---|---|
 |
Global Pharma Services Business Contract Development and
Manufacturing |
|
|
 |
Global Pharma Products Business A strong product portfolio of niche |
Inhalation Anaesthetics
Injectable Anaesthesia /
|
Intrathecal Severe Spasticity /
Injectable for Myxodema Coma
Capsule for type I Gaucher & Niemann-Pick disease:
Others
|
 |
India Consumer Products Business It caters to the Indian self-care market. |
Brands among India’s top OTC brands
|
Presence in Segments
|
KEY DEVELOPMENTS IN FY2019
- Successfully completed 2 USFDA inspections, 42 other
regulatory inspections and 163 customer
audits during FY2019 - Integrated model of services spanning across the entire drug life-cycle
- Over 70 integrated projects completed till date; 28 integrated projects in FY2019
- 13 manufacturing facilities across North America, Europe and Asia
- Built strong capabilities in High Potency APIs and Antibody Drug Conjugates
- Built niche capabilities in injectable anesthesia,
inhalation anesthesia, intrathecal spasticity
and pain management - Integration of key acquired products from Janssen on track
- Launched Sevoflurane Integrated Closure variant in select European countries
- Launched MITGO™ in the US and Miglustat in select European markets
- Added a few brands in the Vitamins, Minerals, and Nutrients category
- E-commerce channel was established in FY2019
- Increasingly using technology and analytics for making decisions in sales and operations
- Direct reach to ~4.2 lakh outlets with chemist coverage comparable to top OTC players
- Large field force of around 2,000 people
- Asset-light model
`4,786 Crores
Revenues
Pharma Revenues (` Crores)
Note: Pharma includes Global Pharma and India Consumer Products
Global Pharma EBITDA Margins (%)
HEALTHCARE INSIGHTS & ANALYTICS
| Business Description | Products/Services | ||
|---|---|---|---|
 |
Healthcare Insights and Analytics The Healthcare Insights and Analytics
business is a premier The Company’s best-in-class methodology,
talent and |
Offerings include
Segments Covered
|
KEY DEVELOPMENTS IN FY2019
- Assisting clients in Pharma, MedTech, Payer, and Provider sectors, addressing some of the most pressing commercial questions facing the healthcare industry
- Margins to improve through strengthening of India presence, with over 400 employees operating out of India
- Addressable market size in excess of $16 Billion
- 100 terabyte, cloud-based, real-world data repository covering >300 Million US patients, and linking >90 Million patients across claims and HER
- Clients including 48 of the top 50 life sciences companies, 18 of the top 20 medical device companies, and 8 of the top 10 US payers and top US health systems
- 96% client retention by value
`1,332 Crores
Revenue
Healthcare Insights & Analytics - Addressable Market Size
($ Billions)
| Healthcare services | Life Sciences | Provider | Payer | Total | |
|---|---|---|---|---|---|
| Solution areas |
Market Research |
3.0 | 0.3 | 0.5 | 3.8 |
Consulting Services |
2.7 | 0.6 | 0.8 | 4.1 | |
Data & Analytics |
4.5 | 2.4 | 1.5 | 8.4 | |
Total |
10.2 | 3.3 | 2.8 | 16.3 |